Jeffrey L. Saver to Chair Astrocyte Pharmaceuticals’ Clinical Advisory Board
Cambridge, MA, December 11, 2018 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, today announced that Jeffrey L. Saver, M.D., has joined the company’s Scientific Advisory Board and will chair the company’s Clinical Advisory Board. Astrocyte Pharmaceuticals is developing small molecule therapeutics for the treatment of brain injuries, including patients who have suffered a …
Jeffrey L. Saver to Chair Astrocyte Pharmaceuticals’ Clinical Advisory Board Read More »